Status:
COMPLETED
Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)
Lead Sponsor:
Hospital Universitari de Bellvitge
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Hemodiafiltration
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
* Study: Open label, non-randomized, observational, descriptive and prospective pharmacokinetic. * Patients: sepsis patients undergoing continuous renal replacement therapy (CRRT) and admitted at the ...
Detailed Description
The study is an open label, non-randomized, observational, descriptive and prospective pharmacokinetic study. Setting: this study will be conducted at the Intensive Care Unit at the Bellvitge Univers...
Eligibility Criteria
Inclusion
- Patients in the setting of sepsis and requirements of CRRT with high adsorption membranes for at least 48 h
- Age \>18 years
- Treatment with piperacillin, ceftazidime, cefepime, ceftolozane and daptomycin prescribed at the discretion of the treating intensive care physician.
- Written informed consent will be required before the inclusion of a patient whenever possible and will be requested from the nearest relatives in the other cases.
Exclusion
- none.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04033029
Start Date
January 1 2021
End Date
June 30 2023
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helena Colom Codina
Barcelona, Spain